Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Imunoglukan P4H Chewable tablets
- Development stage
- Unknown
- Lead developer
- Pleuran
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Imunoglukan P4H Chewable tablets is a marketed food supplement developed by Pleuran to support immune function and bone maintenance, particularly in children and individuals experiencing physical or mental stress. The formulation contains Imunoglukan (IMG), a highly purified natural polysaccharide complex of beta-1,3/1,6-D-glucan extracted from the oyster mushroom (*Pleurotus ostreatus*), combined with zinc and vitamin D3 (cholecalciferol). IMG acts as an immunomodulator by binding to pattern recognition receptors, primarily Dectin-1 (CLEC7A) and complement receptor 3 (CR3), on immune cells in the Peyer's patches of the small intestine, thereby triggering innate and adaptive immune responses. Zinc and vitamin D3 provide synergistic nutritional support, contributing to the normal function of the immune system and the maintenance of healthy bones.
- Brand names
- Defendyl-Imunoglukan P4H D3Defendyl-Imunoglukan P4H D3 chewable tabletsImunoglukan P4H Chewable tabletsImunoglukan P4H Ready
- Other names
- beta-glucan + zinc + vitamin Dpleuran + zinc + vitamin D3
02
Targets
CARD9 (Caspase recruitment domain-containing protein 9)αMβ2 (Integrin αMβ2)SYK (Spleen Tyrosine Kinase)CD36 (CD36 antigen)TLR (Toll-like receptors)VDR (Vitamin D receptor)CLEC7A (Dectin-1)
Beyond the preview
Go deeper on Imunoglukan P4H Chewable tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Imunoglukan P4H Chewable tablets.